0000950123-21-002036.txt : 20210212 0000950123-21-002036.hdr.sgml : 20210212 20210212172516 ACCESSION NUMBER: 0000950123-21-002036 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 EFFECTIVENESS DATE: 20210212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vida Ventures Advisors, LLC CENTRAL INDEX KEY: 0001831423 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20380 FILM NUMBER: 21629885 BUSINESS ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6176489100 MAIL ADDRESS: STREET 1: 40 BROAD STREET STREET 2: SUITE 201 CITY: BOSTON STATE: MA ZIP: 02109 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001831423 XXXXXXXX 12-31-2020 12-31-2020 false Vida Ventures Advisors, LLC
40 Broad Street Suite 201 Boston MA 02109
13F HOLDINGS REPORT 028-20380 Y Certain share holdings that are reported on this 13F were previously reported on a 13F filed by VV Manager, LLC (CIK: 0001735804).
Jean-Philippe Kouakou-Zebouah Chief Financial Officer 857-254-9492 /s/ Jean-Philippe Kouakou-Zebouah San Francisco CA 02-12-2021 0 8 487225 false
INFORMATION TABLE 2 2279.xml INFORMATION TABLE FOR FORM 13F Allogene Therapeutics, Inc. Common Stock 019770106 45386 1798163 SH SOLE 1798163 0 0 Assembly Biosciences, Inc. Common Stock 045396108 2723 450000 SH SOLE 450000 0 0 Dyne Therapeutics, Inc. Common Stock 26818M108 62161 2960046 SH SOLE 2960046 0 0 Homology Medicines, Inc. Common Stock 438083107 8703 770845 SH SOLE 770845 0 0 Kinnate Biopharma, Inc. Common Stock 49705R105 109279 2747074 SH SOLE 2747074 0 0 Kronos Bio, Inc. Common Stock 50107A104 82600 2765314 SH SOLE 2765314 0 0 Oyster Point Pharma, Inc. Common Stock 69242L106 14651 778468 SH SOLE 778468 0 0 Praxis Precision Medicines, Inc. Common Stock 74006W108 161722 2939329 SH SOLE 2939329 0 0